Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Director comp.
Credit agrmnt [a]
Acq. announced
Consulting agrmnt
Quarterly results
|
|
Horizon Therapeutics Public Ltd Co (HZNP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/15/2021 |
8-K
| Quarterly results |
| 12/18/2019 |
8-K
| Credit agreement amendment|
Docs:
|
"Amendment No. 7, to Credit Agreement, (as amended by Amendment No. 1, Amendment No. 2, Amendment No. 3, Amendment No. 4, Amendment No. 5, and Amendment No. 6, dated May 22, 2019), by and among Horizon Therapeutics USA, Inc., as Borrower, Horizon Therapeutics Public Limited Company, as Irish Holdco and a guarantor, the subsidiary guarantors party thereto, as subsidiary guarantors, the lenders party thereto and Citibank, N.A., as administrative agent and collateral agent" |
|
| 05/22/2019 |
8-K
| Credit agreement amendment|
Docs:
|
"Amendment No. 6, to Credit Agreement, (as amended by Amendment No. 1, Amendment No. 2, Amendment No. 3, Amendment No. 4, and Amendment No. 5, dated March 11, 2019), by and among Horizon Pharma USA, Inc., as Borrower, Horizon Therapeutics Public Limited Company, as Irish Holdco and a guarantor, the subsidiary guarantors party thereto, as subsidiary guarantors, the lenders party thereto and Citibank, N.A., as administrative agent and collateral agent" |
|
| 03/11/2019 |
8-K
| Credit agreement amendment|
Docs:
|
"Amendment No. 5. Dated March 11, 2019, to Credit Agreement, (as amended by Amendment No. 1, Amendment No. 2, Amendment No. 3, and Amendment No. 4, dated October 19, 2018), by and among Horizon Pharma USA, Inc., as Borrower, Horizon Pharma Public Limited Company, as Irish Holdco and a guarantor, the subsidiary guarantors party thereto, as subsidiary guarantors, the lenders party thereto and Citibank, N.A., as administrative agent and collateral agent",
"Amendment No. 5. Dated March 11, 2019, to Credit Agreement, (as amended by Amendment No. 1, Amendment No. 2, Amendment No. 3, and Amendment No. 4, dated October 19, 2018), by and among Horizon Pharma USA, Inc., as Borrower, Horizon Pharma Public Limited Company, as Irish Holdco and a guarantor, the subsidiary guarantors party thereto, as subsidiary guarantors, the lenders party thereto and Citibank, N.A., as administrative agent and collateral agent" |
|
| 10/19/2018 |
8-K
| Quarterly results |
| 10/23/2017 |
8-K
| Quarterly results |
| 03/29/2017 |
8-K
| Form 8-K - Current report |
| 10/25/2016 |
8-K
| Form 8-K - Current report |
|
|